PL1735321T3 - Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała - Google Patents

Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała

Info

Publication number: PL1735321T3
Authority: PL; Poland
Prior art keywords: esters; rapamycin; dicarboxylic acid; precursors; antibodies
Prior art date: 2004-04-14

Application number

PL05735488T

Other languages

English (en)

Inventor

Jianxin Gu

Ping Cai

Mark E Ruppen

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-14

Filing date

2005-04-12

Publication date

2009-04-30

2005-04-12 Application filed by Wyeth Corp filed Critical Wyeth Corp

2009-04-30 Publication of PL1735321T3 publication Critical patent/PL1735321T3/pl

Links

ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 title abstract 4
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 title abstract 4
229960002930 sirolimus Drugs 0.000 title abstract 4
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
239000002243 precursor Substances 0.000 title 1
238000000034 method Methods 0.000 abstract 2
102000004882 Lipase Human genes 0.000 abstract 1
108090001060 Lipase Proteins 0.000 abstract 1
239000004367 Lipase Substances 0.000 abstract 1
150000008064 anhydrides Chemical class 0.000 abstract 1
230000001588 bifunctional effect Effects 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
238000006243 chemical reaction Methods 0.000 abstract 1
150000001991 dicarboxylic acids Chemical class 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
235000019421 lipase Nutrition 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Life Sciences & Earth Sciences (AREA)
Wood Science & Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Health & Medical Sciences (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

PL05735488T 2004-04-14 2005-04-12 Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała PL1735321T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US56196604P	2004-04-14	2004-04-14
PCT/US2005/012268 WO2005105812A1 (en)	2004-04-14	2005-04-12	Process for preparing rapamycin 42-esters and fk-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
EP05735488A EP1735321B1 (en)	2004-04-14	2005-04-12	Process for preparing rapamycin 42-esters and fk-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies

Publications (1)

Publication Number	Publication Date
PL1735321T3 true PL1735321T3 (pl)	2009-04-30

Family

ID=34965703

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05735488T PL1735321T3 (pl)	2004-04-14	2005-04-12	Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała

Country Status (14)

Country	Link
US (2)	US7445916B2 (pl)
EP (1)	EP1735321B1 (pl)
JP (1)	JP2007532655A (pl)
CN (1)	CN1942478A (pl)
AT (1)	ATE410431T1 (pl)
AU (1)	AU2005238432A1 (pl)
BR (1)	BRPI0509810A (pl)
CA (1)	CA2562962A1 (pl)
DE (1)	DE602005010228D1 (pl)
DK (1)	DK1735321T3 (pl)
ES (1)	ES2313328T3 (pl)
MX (1)	MXPA06011882A (pl)
PL (1)	PL1735321T3 (pl)
WO (1)	WO2005105812A1 (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2344821C2 (ru)	2002-07-30	2009-01-27	Уайт	Парентеральные композиции, содержащие гидроксиэфиры рапамицина
CA2562962A1 (en) *	2004-04-14	2005-11-10	Wyeth	Process for preparing rapamycin 42-esters and fk-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
MXPA06012404A (es) *	2004-04-27	2007-01-17	Wyeth Corp	Marcado de rapamicina usando metilasas especificas de rapamicina.
PE20060642A1 (es) *	2004-08-10	2006-08-01	Wyeth Corp	Derivados de 42-ester de rapamicina con acido 2,2-bis(hidoximetil)propionico (cci-779) y metodos para su preparacion
US20070128731A1 (en) *	2005-12-07	2007-06-07	Wyeth	Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry
WO2007067560A2 (en) *	2005-12-07	2007-06-14	Wyeth	Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate
BRPI0619493A2 (pt) *	2005-12-07	2016-09-06	Wyeth Corp	forma cristalina purificada de cci-779, processo para a purificação de cc-779, produto, método para monitorar a cristalização de cci-779, kit, composição farmacêutica, método para o tratamento de câncer, e, uso de um cci-779 purificado
CN101394867A (zh) *	2006-03-07	2009-03-25	惠氏公司	大环内酯类免疫抑制剂的水溶性聚乙二醇结合物的制备方法
US8022188B2 (en) *	2006-04-24	2011-09-20	Abbott Laboratories	Immunosuppressant binding antibodies and methods of obtaining and using same
US8414526B2 (en)	2006-11-20	2013-04-09	Lutonix, Inc.	Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8425459B2 (en)	2006-11-20	2013-04-23	Lutonix, Inc.	Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US8414910B2 (en)	2006-11-20	2013-04-09	Lutonix, Inc.	Drug releasing coatings for medical devices
US9700704B2 (en)	2006-11-20	2017-07-11	Lutonix, Inc.	Drug releasing coatings for balloon catheters
US8998846B2 (en)	2006-11-20	2015-04-07	Lutonix, Inc.	Drug releasing coatings for balloon catheters
US20080276935A1 (en)	2006-11-20	2008-11-13	Lixiao Wang	Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US20080175887A1 (en)	2006-11-20	2008-07-24	Lixiao Wang	Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
US8414525B2 (en)	2006-11-20	2013-04-09	Lutonix, Inc.	Drug releasing coatings for medical devices
US9737640B2 (en)	2006-11-20	2017-08-22	Lutonix, Inc.	Drug releasing coatings for medical devices
TW200845960A (en) *	2007-04-05	2008-12-01	Wyeth Corp	Wortmannin-rapalog conjugate and uses thereof
WO2010024898A2 (en)	2008-08-29	2010-03-04	Lutonix, Inc.	Methods and apparatuses for coating balloon catheters
PT2365802T (pt)	2008-11-11	2017-11-14	Univ Texas	Microcápsulas de rapamicina e utilização para o tratamento de cancro
US9283211B1 (en)	2009-11-11	2016-03-15	Rapamycin Holdings, Llc	Oral rapamycin preparation and use for stomatitis
KR101742406B1 (ko)	2012-08-16	2017-05-31	화이자 인코포레이티드	당접합 공정 및 조성물
EP2968281B1 (en)	2013-03-13	2020-08-05	The Board of Regents of The University of Texas System	Mtor inhibitors for prevention of intestinal polyp growth
DK3089737T3 (da)	2013-12-31	2021-12-13	Rapamycin Holdings Llc	Orale rapamycin-nanopartikelpræparater og anvendelse.
US9700544B2 (en)	2013-12-31	2017-07-11	Neal K Vail	Oral rapamycin nanoparticle preparations
EP3624863B1 (en)	2017-05-15	2021-04-14	C.R. Bard, Inc.	Medical device with drug-eluting coating and intermediate layer
JP7262581B2 (ja)	2018-11-14	2023-04-21	ルトニックス，インコーポレーテッド	改質されたデバイス表面に薬物溶出コーティングを有する医療用デバイス
JP7487228B2 (ja)	2019-04-08	2024-05-20	バード・ペリフェラル・バスキュラー・インコーポレーテッド	改質されたデバイス表面に薬物溶出コーティングを有する医療用デバイス
CN118027062B (zh) *	2023-11-03	2025-02-14	沈阳药科大学	一种雷帕霉素前药及其纳米制剂的制备和应用

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA737247B (en)	1972-09-29	1975-04-30	Ayerst Mckenna & Harrison	Rapamycin and process of preparation
US4316885A (en) *	1980-08-25	1982-02-23	Ayerst, Mckenna And Harrison, Inc.	Acyl derivatives of rapamycin
US4650803A (en) *	1985-12-06	1987-03-17	University Of Kansas	Prodrugs of rapamycin
US5210030A (en)	1990-06-25	1993-05-11	Merck & Co., Inc.	Process for selectively acylating immunomycin
US5023264A (en) *	1990-07-16	1991-06-11	American Home Products Corporation	Rapamycin oximes
US5221670A (en) *	1990-09-19	1993-06-22	American Home Products Corporation	Rapamycin esters
PT98990A (pt) *	1990-09-19	1992-08-31	American Home Prod	Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
US5378696A (en) *	1990-09-19	1995-01-03	American Home Products Corporation	Rapamycin esters
US5130307A (en) *	1990-09-28	1992-07-14	American Home Products Corporation	Aminoesters of rapamycin
US5233036A (en) *	1990-10-16	1993-08-03	American Home Products Corporation	Rapamycin alkoxyesters
US5080899A (en)	1991-02-22	1992-01-14	American Home Products Corporation	Method of treating pulmonary inflammation
US5078999A (en)	1991-02-22	1992-01-07	American Home Products Corporation	Method of treating systemic lupus erythematosus
US5120842A (en)	1991-04-01	1992-06-09	American Home Products Corporation	Silyl ethers of rapamycin
US5100883A (en)	1991-04-08	1992-03-31	American Home Products Corporation	Fluorinated esters of rapamycin
US5118678A (en) *	1991-04-17	1992-06-02	American Home Products Corporation	Carbamates of rapamycin
US5118667A (en)	1991-05-03	1992-06-02	Celtrix Pharmaceuticals, Inc.	Bone growth factors and inhibitors of bone resorption for promoting bone formation
US5130507A (en) *	1991-05-23	1992-07-14	Eaton Corporation	Capacitive switch assembly
ES2084940T3 (es)	1991-06-18	1996-05-16	American Home Prod	Uso de la rapamicina para el tratamiento de la leucemia/linfoma de las celulas t adultas.
US5162333A (en) *	1991-09-11	1992-11-10	American Home Products Corporation	Aminodiesters of rapamycin
US5177203A (en) *	1992-03-05	1993-01-05	American Home Products Corporation	Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
US5256790A (en) *	1992-08-13	1993-10-26	American Home Products Corporation	27-hydroxyrapamycin and derivatives thereof
GB9221220D0 (en) *	1992-10-09	1992-11-25	Sandoz Ag	Organic componds
US5302584A (en) *	1992-10-13	1994-04-12	American Home Products Corporation	Carbamates of rapamycin
US5411967A (en) *	1992-10-13	1995-05-02	American Home Products Corporation	Carbamates of rapamycin
US5489680A (en) *	1992-10-13	1996-02-06	American Home Products Corporation	Carbamates of rapamycin
US5480988A (en) *	1992-10-13	1996-01-02	American Home Products Corporation	Carbamates of rapamycin
US5434260A (en) *	1992-10-13	1995-07-18	American Home Products Corporation	Carbamates of rapamycin
US5480989A (en) *	1992-10-13	1996-01-02	American Home Products Corporation	Carbamates of rapamycin
US5262423A (en) *	1992-10-29	1993-11-16	American Home Products Corporation	Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
US5258389A (en) *	1992-11-09	1993-11-02	Merck & Co., Inc.	O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
US5260300A (en) *	1992-11-19	1993-11-09	American Home Products Corporation	Rapamycin carbonate esters as immuno-suppressant agents
US5252579A (en) *	1993-02-16	1993-10-12	American Home Products Corporation	Macrocyclic immunomodulators
GB9307491D0 (en)	1993-04-08	1993-06-02	Sandoz Ltd	Organic compounds
US5504091A (en) *	1993-04-23	1996-04-02	American Home Products Corporation	Biotin esters of rapamycin
AU686629B2 (en) *	1993-04-23	1998-02-12	Wyeth	Rapamycin Conjugates and Antibodies
AU6711994A (en)	1993-04-23	1994-11-21	American Home Products Corporation	Rapamycin conjugates and antibodies
GB2281294A (en)	1993-08-23	1995-03-01	Fujisawa Pharmaceutical Co	Process for producing half esters of the macrolide FK506
US5378836A (en) *	1993-10-08	1995-01-03	American Home Products Corporation	Rapamycin oximes and hydrazones
US5391730A (en) *	1993-10-08	1995-02-21	American Home Products Corporation	Phosphorylcarbamates of rapamycin and oxime derivatives thereof
US5373014A (en) *	1993-10-08	1994-12-13	American Home Products Corporation	Rapamycin oximes
US5385910A (en) *	1993-11-22	1995-01-31	American Home Products Corporation	Gem-distributed esters of rapamycin
US5385908A (en) *	1993-11-22	1995-01-31	American Home Products Corporation	Hindered esters of rapamycin
US5385909A (en) *	1993-11-22	1995-01-31	American Home Products Corporation	Heterocyclic esters of rapamycin
US5389639A (en) *	1993-12-29	1995-02-14	American Home Products Company	Amino alkanoic esters of rapamycin
US5362718A (en) *	1994-04-18	1994-11-08	American Home Products Corporation	Rapamycin hydroxyesters
US5463048A (en) *	1994-06-14	1995-10-31	American Home Products Corporation	Rapamycin amidino carbamates
US5491231A (en) *	1994-11-28	1996-02-13	American Home Products Corporation	Hindered N-oxide esters of rapamycin
US5563145A (en) *	1994-12-07	1996-10-08	American Home Products Corporation	Rapamycin 42-oximes and hydroxylamines
US6261813B1 (en) *	1995-09-11	2001-07-17	Albany Molecular Research, Inc.	Two step enzymatic acylation
US5780462A (en) *	1995-12-27	1998-07-14	American Home Products Corporation	Water soluble rapamycin esters
JP2001518784A (ja)	1997-04-09	2001-10-16	アイソテクニカ，インコーポレイテッド	ラパマイシンの特異的部位に対する抗体の産生方法
US6277983B1 (en)	2000-09-27	2001-08-21	American Home Products Corporation	Regioselective synthesis of rapamycin derivatives
US7153983B2 (en) *	2002-03-25	2006-12-26	Council Of Scientific And Industrial Research	Chemo-enzymatic process for the preparation of opticaly enriched β-benzyl-γ-butyrolactones
US6745478B2 (en)	2002-07-18	2004-06-08	Delillo Dominick D.	Multi-purpose work knife
PT1658295E (pt)	2003-08-07	2007-09-25	Wyeth Corp	Síntese regiosselectiva de cci-779
US7202256B2 (en) *	2004-04-14	2007-04-10	Wyeth	Proline CCI-779, production of and uses therefor, and two-step enzymatic synthesis of proline CCI-779 and CCI-779
AU2005238431A1 (en) *	2004-04-14	2005-11-10	Wyeth	Regiospecific synthesis of rapamycin 42-ester derivatives
CA2562962A1 (en) *	2004-04-14	2005-11-10	Wyeth	Process for preparing rapamycin 42-esters and fk-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
WO2006004803A1 (en) *	2004-06-30	2006-01-12	Combinatorx, Incorporated	Methods and reagents for the treatment of metabolic disorders

2005
- 2005-04-12 CA CA002562962A patent/CA2562962A1/en not_active Abandoned
- 2005-04-12 DE DE602005010228T patent/DE602005010228D1/de not_active Expired - Fee Related
- 2005-04-12 MX MXPA06011882A patent/MXPA06011882A/es active IP Right Grant
- 2005-04-12 US US11/104,349 patent/US7445916B2/en not_active Expired - Lifetime
- 2005-04-12 WO PCT/US2005/012268 patent/WO2005105812A1/en not_active Ceased
- 2005-04-12 AU AU2005238432A patent/AU2005238432A1/en not_active Withdrawn
- 2005-04-12 ES ES05735488T patent/ES2313328T3/es not_active Expired - Lifetime
- 2005-04-12 AT AT05735488T patent/ATE410431T1/de not_active IP Right Cessation
- 2005-04-12 EP EP05735488A patent/EP1735321B1/en not_active Expired - Lifetime
- 2005-04-12 BR BRPI0509810-6A patent/BRPI0509810A/pt not_active IP Right Cessation
- 2005-04-12 JP JP2007508443A patent/JP2007532655A/ja not_active Withdrawn
- 2005-04-12 CN CNA200580011299XA patent/CN1942478A/zh not_active Withdrawn
- 2005-04-12 DK DK05735488T patent/DK1735321T3/da active
- 2005-04-12 PL PL05735488T patent/PL1735321T3/pl unknown
2008
- 2008-09-29 US US12/240,230 patent/US7625726B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE602005010228D1 (de)	2008-11-20
CA2562962A1 (en)	2005-11-10
JP2007532655A (ja)	2007-11-15
ATE410431T1 (de)	2008-10-15
DK1735321T3 (da)	2009-01-12
US7445916B2 (en)	2008-11-04
MXPA06011882A (es)	2006-12-14
US20050234087A1 (en)	2005-10-20
WO2005105812A1 (en)	2005-11-10
BRPI0509810A (pt)	2007-09-18
ES2313328T3 (es)	2009-03-01
EP1735321A1 (en)	2006-12-27
US7625726B2 (en)	2009-12-01
CN1942478A (zh)	2007-04-04
AU2005238432A1 (en)	2005-11-10
EP1735321B1 (en)	2008-10-08
US20090029426A1 (en)	2009-01-29

Publication	Publication Date	Title
PL1735321T3 (pl)	2009-04-30	Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała
WO2006078809A3 (en)	2007-07-12	Method for the preparation of maytansinoid esters
WO2003082795A3 (en)	2003-12-24	METHODS OF MANUFACTURING DERIVATIVES OF β-HYDROXYCARBOXYLIC ACIDS
EP1077212A4 (en)	2001-11-21	METHOD FOR PRODUCING VIVIVES OF 6-CYANOMETHYL-1,3-DIOXANE-4-ACETIC ACID
TW200745015A (en)	2007-12-16	Process for the preparation of carboxylic acids and/or derivatives thereof
WO2007147827A3 (en)	2008-06-12	Production of pravastatin
Gruttadauria et al.	2004	Short and efficient chemoenzymatic synthesis of goniothalamin
WO2005105768A3 (en)	2006-03-16	Process for preparation of mycophenolic acid and ester derivatives thereof
WO2010037653A9 (en)	2010-05-27	Apparatus and process for gas phase fluidised bed polymerisation reaction
WO2004104205A3 (en)	2005-08-04	Enzymatic preparation of chiral indole esters
Klomp et al.	2005	Enzymatic kinetic resolution of tropic acid
ZA200409433B (en)	2005-07-14	Process for the preparation of carboxylic acid esters.
HUP0204173A2 (hu)	2003-03-28	Eljárás konjugált linolénsav előállítására
TW200609211A (en)	2006-03-16	Esterification catalyst and process therewith
WO2007026373A3 (en)	2007-07-12	Process for preparing rivastigmine
TWI318583B (en)	2009-12-21	Catalyst and process for preparing carboxylic acid esters
EP1777295A3 (en)	2007-06-20	A process for the preparation of (-) modafinil
Zheng	1997	Photochemical reactions of 2, 3-dihydro-4-pyridones and their application in natural product synthesis: Total synthesis of plumerinine and perhydrohistrionicotoxin.
WO2006133332A3 (en)	2007-02-01	Enzyme-catalyzed process for the preparation of macrocyclic polyester oligomers
HUP0201574A2 (en)	2002-08-28	Process for the preparation of fumagillin
WO2006105051A3 (en)	2007-02-22	Synthesis of diketopiperazines
HUP0105000A3 (en)	2004-03-01	Process for producing hmg-coa reductase inhibitors
Schink	1993	1, 4-Allylic stereocontrol via palladium catalysis in the synthesis of some natural products.
TW200604143A (en)	2006-02-01	Method of preparing cyclopentene nitrile derivatives
GB2428014B (en)	2010-02-10	Catalyst and process for preparing carboxylic acid esters